Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 4 (2007), Issue 6 (June)

1. Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation.
   J Mol Med, 85(6): 635-45. [Abstract] [Full-text]
2. Substance use in a population-based clinic sample of people with first-episode psychosis.
   Br J Psychiatry, 190: 515-20. [Abstract] [Full-text]
3. Cannabinoid concentrations in hair from documented cannabis users.
   Forensic Sci Int, 169(2): 129-36. [Abstract] [Full-text]
4. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities.
   Int J Cardiol, 119(2): 235-6. [Abstract] [Full-text]
5. Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid.
   J Chromatogr B Analyt Technol Biomed Life Sci, 852(1): 459-64. [Abstract] [Full-text]
6. Pre-natal exposures to cocaine and alcohol and physical growth patterns to age 8 years.
   Neurotoxicol Teratol, 29(4): 446-57. [Abstract] [Full-text]
7. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
   Schizophr Res, 93(1): 203-10. [Abstract] [Full-text]
8. Cross-sectional study of female students reporting anabolic steroid use.
   Arch Pediatr Adolesc Med, 161(6): 572-7. [Abstract] [Full-text]
9. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
   Arch Gen Psychiatry, 64(6): 728-36. [Abstract] [Full-text]
10. Prevalence and correlates of cannabis use in developed and developing countries.
    Curr Opin Psychiatry, 20(4): 393-7. [Abstract] [Full-text]
11. An MR-compatible device for delivering smoked marijuana during functional imaging.
    Pharmacol Biochem Behav, 87(1): 81-9. [Abstract] [Full-text]
12. Retail marijuana purchases in designer and commercial markets in New York City: sales units, weights, and prices per gram.
    Drug Alcohol Depend, 90: S40-51. [Abstract] [Full-text]
13. How much for a dime bag? An exploration of youth drug markets.
    Drug Alcohol Depend, 90: S27-39. [Abstract] [Full-text]
14. Education inequality and use of cigarettes, alcohol, and marijuana.
    Drug Alcohol Depend, 90: S4-15. [Abstract] [Full-text]
15. MDMA attenuates THC withdrawal syndrome in mice.
    Psychopharmacology (Berl), 193(1): 75-84. [Abstract] [Full-text]
16. Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics.
    Exp Clin Psychopharmacol, 15(3): 272-81. [Abstract] [Full-text]
17. Young-adult malt liquor drinkers: prediction of alcohol problems and marijuana use.
    Psychol Addict Behav, 21(2): 138-46. [Abstract] [Full-text]
18. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
    Br J Pharmacol, 151(4): 427-40. [Abstract] [Full-text]
19. Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review.
    Eur Child Adolesc Psychiatry, 16(4): 243-53. [Abstract] [Full-text]
20. Toxicological investigation of drug-related cases in Greece: interpretation of analytical findings.
    Int J Toxicol, 26(3): 231-6. [Abstract] [Full-text]
21. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study.
    Addiction, 102(7): 1122-30. [Abstract] [Full-text]
22. Crystal methamphetamine use among young adults in the USA.
    Addiction, 102(7): 1102-13. [Abstract] [Full-text]
23. The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study.
    Addiction, 102(7): 1076-84. [Abstract] [Full-text]
24. Pharmacokinetics of 11-nor-9-Carboxy-Delta(9)-Tetrahydrocannabinol (CTHC) After Intravenous Administration of CTHC in Healthy Human Subjects.
    Clin Pharmacol Ther, 82(1): 63-9. [Abstract] [Full-text]
25. Socioeconomic status and health behaviors in adolescence: a review of the literature.
    J Behav Med, 30(3): 263-85. [Abstract] [Full-text]
26. Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa.
    FEBS Lett, 581(16): 2929-34. [Abstract] [Full-text]
27. Motor effects of delta 9 THC in cerebellar Lurcher mutant mice.
    Behav Brain Res, 181(2): 248-53. [Abstract] [Full-text]
28. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma.
    J Biol Chem, 282(25): 18625-33. [Abstract] [Full-text]
29. Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects.
    Psychol Med, 37(7): 935-45. [Abstract] [Full-text]
30. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Psychol Med, 37(7): 927-34. [Abstract] [Full-text]
31. Marijuana use patterns among African-American middle-school students: a longitudinal latent class regression analysis.
    Drug Alcohol Depend, 90(1): 12-24. [Abstract] [Full-text]
32. Cannabis use and symptom experience amongst people with mental illness: a commentary on Degenhardt et al.
    Psychol Med, 37(7): 913-6. [Abstract] [Full-text]
33. The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task.
    Drug Alcohol Depend, 90(1): 2-11. [Abstract] [Full-text]
34. Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey.
    Drug Alcohol Depend, 90(1): 72-80. [Abstract] [Full-text]
35. Longitudinal modeling of genetic and environmental influences on self-reported availability of psychoactive substances: alcohol, cigarettes, marijuana, cocaine and stimulants.
    Psychol Med, 37(7): 947-59. [Abstract] [Full-text]
36. Adolescent tobacco and cannabis use: young adult outcomes from the Ontario Child Health Study.
    J Child Psychol Psychiatry, 48(7): 724-31. [Abstract] [Full-text]
37. The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians.
    Am J Med Genet B Neuropsychiatr Genet, 144(5): 660-6. [Abstract] [Full-text]
38. Transcriptional profiling of subjects from the Iowa adoption studies.
    Am J Med Genet B Neuropsychiatr Genet, 144(5): 683-90. [Abstract] [Full-text]
39. Cannabis treatment outcomes among legally coerced and non-coerced adults.
    BMC Public Health, 7: 111. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.